TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 105 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $288,000 | -18.6% | 4,330 | -25.2% | 0.02% | -31.8% |
| Q1 2020 | $354,000 | -38.2% | 5,785 | -11.2% | 0.02% | 0.0% |
| Q4 2019 | $573,000 | +5.9% | 6,515 | -9.2% | 0.02% | -8.3% |
| Q3 2019 | $541,000 | -26.7% | 7,175 | -16.9% | 0.02% | -17.2% |
| Q2 2019 | $738,000 | -45.1% | 8,635 | -30.6% | 0.03% | -37.0% |
| Q1 2019 | $1,344,000 | +26.1% | 12,435 | -1.3% | 0.05% | +39.4% |
| Q4 2018 | $1,066,000 | -7.9% | 12,600 | +7.0% | 0.03% | +17.9% |
| Q3 2018 | $1,157,000 | -15.5% | 11,775 | -0.5% | 0.03% | -15.2% |
| Q2 2018 | $1,369,000 | -1.3% | 11,830 | -15.8% | 0.03% | +6.5% |
| Q1 2018 | $1,387,000 | – | 14,045 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |